Weight Loss Injection

Product Details:

 

Tirzepatide is a once-weekly injectable medication used to treat:

• Type 2 Diabetes Mellitus

• Obesity or overweight (with weight-related health risks)

It is sold under the brand name Mounjaro (and others in some countries) and comes in doses ranging from 2.5 mg to 15 mg per injection. The 2.5 mg dose is typically used as the starting dose.

🧬 Class & Mechanism

Tirzepatide is a dual GIP and GLP-1 receptor agonist:

• GIP: Glucose-dependent Insulinotropic Polypeptide

• GLP-1: Glucagon-Like Peptide-1

These are natural gut hormones (incretins) that:

• Stimulate insulin release when blood sugar is high

• Suppress glucagon (which raises blood sugar)

• Slow stomach emptying

• Reduce appetite, helping with weight loss

By targeting both GIP and GLP-1 receptors, tirzepatide has enhanced glucose control and significant weight loss effects.

✅ Uses & Indications

1. Type 2 Diabetes Mellitus

   • To improve blood sugar control in adults

   • Often used alongside diet and exercise

   • May be combined with metformin, insulin, or other oral antidiabetics

2. Obesity Management (off-label or approved in some regions)

   • For adults with BMI ≥30 or ≥27 with related health risks

   • Promotes weight loss by reducing appetite and improving metabolic function

💉 Dosage & Administration

• Starting dose: 2.5 mg subcutaneously once weekly

• After 4 weeks, the dose is increased to 5 mg

• Can be gradually increased to up to 15 mg weekly based on response and tolerance

How to use:

• Inject under the skin (abdomen, thigh, or upper arm)

• Rotate injection sites

• Can be taken with or without food

• Use same day each week; if missed, can take within 4 days

🧪 Side Effects

Common:

• Nausea, vomiting

• Diarrhea or constipation

• Decreased appetite

• Indigestion

Serious (rare):

• Pancreatitis (inflammation of the pancreas)

• Gallbladder disease

• Kidney injury (from dehydration)

• Allergic reactions

• Thyroid C-cell tumors (observed in animals)

⚠️ Precautions & Warnings

• Not for Type 1 Diabetes or ketoacidosis

• Avoid if personal/family history of medullary thyroid cancer or MEN 2 syndrome

• Caution in patients with gastrointestinal disorders

• Monitor for signs of pancreatitis (severe stomach pain, vomiting)

• Not recommended during pregnancy or breastfeeding

• Not a substitute for insulin in insulin-dependent diabetics

Additional Information:

• Production Capacity: 25000 injection per month
• Delivery Time: 2-5 Days
• Packaging Details: ALL MEDICINES ARE WELL PACKED IN BROWN CARD BOX WITH THARMACOLE AND PLASTIC TO MAKE DECENT PACKING AND PREVENT FROM ANY TYPE OF PRODUCT DAMAGE .